权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

2023 Cell Growth and Proliferation Gordon Research Conference and Seminar

2023年细胞生长与增殖戈登研究会议暨研讨会

基本信息

批准号：
10748652
负责人：
MARTINE F. ROUSSEL (SHERR)
金额：
$ 1.2万
依托单位：
GORDON RESEARCH CONFERENCES
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-07-01 至 2024-04-08
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10748652
关键词：
Abnormal Cell Academia Acceleration Aging Area Atmosphere Autoimmune Diseases Automobile Driving Biology CDK4 gene Cell Cycle Cell Cycle Progression Cell Cycle Regulation Cell Proliferation Cell division Cells Cellular biology Clinical Trials Collaborations Communication Communities Dedications Degenerative Disorder Development Developmental Biology Discipline Disease Epigenetic Process Estrogen receptor positive Event FDA approved Faculty Fostering Funding Genetic Genome Stability Genomics Geography Goals Government Growth Heterogeneity Human Immunity Immunologic Deficiency Syndromes Industry Investigation Leadership Letrozole Malignant Neoplasms Mentors Metabolic Diseases Normal Cell Participant Pharmaceutical Preparations Physiology Postdoctoral Fellow Proliferating Recording of previous events Research Research Personnel Resort Schedule Scientist Signal Pathway Signal Transduction Structure Students Systems Biology Therapeutic Time Underrepresented Populations Variant Vermont Woman Work cancer cell cancer therapy career career development cell growth developmental disease genome integrity graduate student inhibitor invention kinase inhibitor malignant breast neoplasm meetings member minority scientist model organism new technology outreach posters programs protein degradation senior faculty success symposium tool

项目摘要

SUMMARY This proposal is a request for support from the NCI for partial support of the Gordon Research Conference (GRC) “Cell Growth and Proliferation: Cell Cycle and Proliferation in Development and Cancer.” The conference will gather 150-200 graduate students, postdoctoral fellows, staff scientists, junior and senior faculty, lab leaders in industry and government for discussions of their most recent unpublished discoveries. The Conference will focus on mechanisms of normal cell proliferation control, the many cell cycle variations required for normal growth, and the variety of abnormal cell cycle perturbations in cancer and other proliferative diseases. The program format is an approximately equal mix of invited speakers with speakers selected from abstract submitted in the spring of 2023 with an emphasis on broad representation of speakers from multiple disciplines, career stages, demographic and geographic backgrounds. The Chair and Vice Chair are specifically committed to creating a diverse and inclusive conference that reflects the breadth of cell cycle control and fundamental cancer cell biology research and that showcases the contributions of both junior and senior members of the field; 44% of the confirmed invited speakers are women and all discussants are women. Topics of formal research sessions planned include an opening session focused on Protein Degradation in Development and Cancer and additional sessions including 1) Cell Cycle Machinery and Cell Division, 2) Proliferation and Genome Stability, 3) Mechanisms of Cell Cycle Progression and Quiescence, 4) Driving the Cell Cycle, 4) Targeting CDKs in Cancer, 5) Signaling Pathways in Development and Cancer, 6) Genome Integrity and Immunity, and 7) System biology and Genomics. In addition, there will be four poster sessions and ample unstructured time for informal networking. We will also use funding to partially support the affiliated Gordon Research Seminar (GRS). The GRS is a 1.5day event that immediately precedes the GRC organized by and for postdocs and students to present their work and engage in career development. Both events will be held at Mount Snow Resort, West Dover, Vermont from July 9-14, 2023, and the GRC is a major conference relatively unique in its breadth because it brings together researchers focused on basic and translational biology from academic and industry settings.

总结该提案是NCI对戈登研究会议（GRC）部分支持的请求 “细胞生长和增殖：发育和癌症中的细胞周期和增殖。会议将聚集150-200名研究生，博士后研究员，工作人员科学家，初级和高级教师，实验室负责人，工业界和政府讨论他们最近未发表的发现。会议将集中关于正常细胞增殖控制的机制，正常生长所需的许多细胞周期变化，以及癌症和其它增殖性疾病中的多种异常细胞周期扰动。程序格式是邀请的演讲者与从提交的摘要中选择的演讲者的大致相等的混合。 2023年春季，强调来自多个学科，职业阶段，人口和地理背景。主席和副主席特别致力于建立一个多样化和包容性的会议，反映了细胞周期控制和基本癌细胞的广度生物学研究，展示了该领域初级和高级成员的贡献; 44%的已确认的受邀发言者是妇女，所有讨论者都是妇女。正式研究会议的主题计划包括一个开幕会议，重点是蛋白质降解在发展和癌症和其他会议包括1）细胞周期机制和细胞分裂，2）增殖和基因组稳定性，3）细胞周期进展和静止的机制，4）驱动细胞周期，4）靶向癌症中的CDK， 5)发育和癌症中的信号通路，6）基因组完整性和免疫力，以及7）系统生物学和基因组学此外，还将举行四次海报会议，联网我们还将使用资金部分支持附属戈登研究研讨会（GRS）。的 GRS是一个为期1.5天的活动，紧接在GRC之前，由博士后和学生组织，介绍他们的工作并参与职业发展。这两项活动都将在西雪山度假村举行 2023年7月9日至14日，佛蒙特州多佛，GRC是一个在广度上相对独特的主要会议，因为它汇集了来自学术和行业背景的专注于基础和转化生物学的研究人员。